TheraSphere With Durvalumab and Tremelimumab for HCC
Public ClinicalTrials.gov record NCT05063565. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Prospective, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of TheraSphere™ Followed by Durvalumab (Imfinzi®) With Tremelimumab (Imjudo®) for Hepatocellular Carcinoma (HCC)
Study identification
- NCT ID
- NCT05063565
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Durvalumab (Imfinzi) immunotherapy Drug
- TheraSphere Y-90 glass microsphere therapy Device
- Tremelimumab immunotherapy Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2, 2023
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
- Last update posted
- Apr 28, 2026
2023 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona- Banner Health | Tucson | Arizona | 85724 | — |
| University of California San Diego | San Diego | California | 92093 | — |
| University of California San Francisco | San Francisco | California | 94143 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Chicago Hospital | Chicago | Illinois | 60637 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University (Barnes-Jewish Hospital) | St Louis | Missouri | 63101 | — |
| Columbia University Irving Medical Center | New York | New York | 10032 | — |
| Intermountain Health | Salt Lake City | Utah | 84157 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05063565, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05063565 live on ClinicalTrials.gov.